ABMD 34.76 Abiomed $ABMD Hit a 52 week high of 34.98

New Post Public Reply Private Reply Replies (0) Message Board

Nov 19, 2014 at 10:06 AM

ABMD 34.76 Abiomed $ABMD Hit a 52 week high of 34.98 Closing the day 09:44 at 34.76 -0.12 -0.34% With a day low of 34.75 and a total volume of 7,557.

ABMD Recent Posts: http://investorshangout.com/Abiomed-ABMD-53201/

ABMD Abiomed Recent Headline News

ABIOMED Earnings In Retrospect: Up 6.1% in the Last 18 Days (ABMD)
Comtex SmarTrend(R) - Mon Nov 17, 12:42PM CST
When ABIOMED (NASDAQ:ABMD) reported earnings 18 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.02 on sales of $50.1 million. ABIOMED actually reported earnings of $0.09 per share on sales of $51.9 million, beating EPS estimates by $0.07 and beating revenue estimates by $1.8 million. Shares of ABIOMED have climbed from $31.35 to $33.25, representing a gain of 6.1% since the company reported earnings 18 days ago.
ABMD: 34.76 (-0.12)

Abiomed to Present at the Jefferies 2014 Global Healthcare Conference
GlobeNewswire - Mon Nov 17, 7:18AM CST
Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Robert L. Bowen, Vice President & Chief Financial Officer, will present at the Jefferies 2014 Global Healthcare Conference on November 20, 2014 at 10:40 a.m. GMT. The conference will be held at The Waldorf Hilton London in London, UK.
ABMD: 34.76 (-0.12)

Varian Medical (VAR) Down to Strong Sell on Dismal Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:20PM CST
On Nov 14, 2014, Zacks Investment Research downgraded Varian Medical Systems (VAR) to a Zacks Rank #5 (Strong Sell).
ABMD: 34.76 (-0.12), VAR: 88.06 (-0.29), EW: 127.26 (-0.62), ANGO: 16.84 (-0.02)

ABIOMED (ABMD) Stock: Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 6:33AM CST
ABIOMED (ABMD) Stock: Moving Average Crossover Alert
ABMD: 34.76 (-0.12)

Thoratec (THOR) Down to Strong Sell on Growing Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:20PM CST
On Nov 11, 2014, Zacks Investment Research downgraded Thoratec Corp. (THOR) to a Zacks Rank #5 (Strong Sell).
ABMD: 34.76 (-0.12), EW: 127.26 (-0.62), THOR: 29.78 (-0.11), ANGO: 16.84 (-0.02)

Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 34.76 (-0.12), FLDM: 30.33 (-0.60), GMED: 22.65 (-0.25), ANGO: 16.84 (-0.02)

ABIOMED Shares Up 34.3% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Wed Nov 12, 9:15AM CST
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on October 28th, 2014 at $24.67. In approximately 2 weeks, ABIOMED has returned 34.28% as of today's recent price of $33.13.
ABMD: 34.75 (-0.13)

Mettler-Toledo (MTD) Tops Q3 Earnings on Revenue Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 8:34AM CST
Mettler-Toledo International Inc. (MTD) reported adjusted earnings per share (EPS) of $2.95 for the third quarter of fiscal 2014, which beat the Zacks Consensus Estimate of $2.86. Adjusted EPS also improved 13% from the year-ago quarter.
ABMD: 34.75 (-0.13), FLDM: 30.33 (-0.60), ANGO: 16.84 (-0.02), MTD: 291.89 (+0.24)

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:11AM CST
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 34.75 (-0.13), ROKA: 3.90 (-0.05), EW: 127.26 (-0.62), ANGO: 16.84 (-0.02)

OTC Daily Alert Stock Watch - ABIOMED, Inc. (NASDAQ: ABMD)
WorldStockWire - Mon Nov 10, 12:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
ABMD: 34.75 (-0.13)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 34.75 (-0.13), VOLC: 11.11 (-0.14), EW: 127.26 (-0.62), ANGO: 16.84 (-0.02)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 34.75 (-0.13), DXCM: 51.59 (unch), EW: 127.26 (-0.62), ANGO: 16.84 (-0.02)

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 108.10 (-0.02), ABMD: 34.75 (-0.13), JNJ: 108.35 (-0.48), AMGN: 161.15 (-1.09), EXAS: 22.75 (-0.05), ARAY: 7.45 (+0.08), HOLX: 26.52 (-0.12), PBYI: 219.91 (-3.09)

Update: Abiomed's Q2 Fiscal 2015 Earnings Remained Impressive
Andy Batts - at Seeking Alpha - Sat Nov 08, 4:40PM CST

ABMD: 34.75 (-0.13)

Hologic Beats Q4 Earnings, Sales as All Segments Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:50PM CST
Hologic (HOLX) entered into an amended license agreement with Roka Bioscience, which earned a one-time revenue benefit of $20.1 million for Hologic
ABMD: 34.75 (-0.13), DXCM: 51.59 (unch), ANGO: 16.84 (-0.02), HOLX: 26.52 (-0.12)

Thoratec Q3 Earnings & Revenues Lag Estimates, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:00AM CST
Following the earnings release, shares of Thoratec Corp. (THOR) declined approximately 3.5% to close at $26.10 yesterday.
ABMD: 34.75 (-0.13), CYNO: 26.50 (-0.40), THOR: 29.78 (-0.11), ANGO: 16.84 (-0.02)

Abiomed (ABMD) Upgraded From Hold to Buy
at The Street - Fri Nov 07, 8:07AM CST
Abiomed (ABMD) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
ABMD: 34.75 (-0.13)

Foundation Medicine Slumps: FMI Tumbles 9.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:59AM CST
Foundation Medicine has been witnessing a flat trend in its current year earnings estimate and its share price has been falling for past 24 hours
ABMD: 34.75 (-0.13), DXCM: 51.59 (unch), FMI: 25.71 (-0.15), ANGO: 16.84 (-0.02)

Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 34.75 (-0.13), FLDM: 30.33 (-0.60), ANGO: 16.84 (-0.02), MR: 30.88 (+0.12)

Abiomed Tops Q2 Earnings, Revenues; FY15 Sales View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:10PM CST
Abiomed Inc. (ABMD) reported second-quarter fiscal 2015 earnings of 9 cents per share, outshining the Zacks Consensus Estimate of 2 cents.
ABMD: 34.75 (-0.13), FLDM: 30.33 (-0.60), BEAT: 8.38 (-0.09), ANGO: 16.84 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Schweid & Sons Reveals New Marinated Steak Tips Line

No More Prep Dilemmas: Schweid & Sons Unveils Steak Tips Packing a punch in the protein aisle, Schweid & Sons throws down the gauntlet with their latest culinary innovation — Marinated Steak Tips. These aren't just your run-of-the-mill cuts, folks. We're talking premium Tri-Tip, butcher-trimmed to perfection, and marinated in both Cajun and Teriyaki styles. It's all...

Craig Hospital Expands: A Milestone for Rehab Care

A Bold Step Forward in Neurorehabilitation Over a September sky in Englewood, Colorado, a ceremonial beam rose, marking a major milestone for Craig Hospital. It's not just steel and concrete; it's hope and progress for many who've found themselves at the mercy of neurological injuries. Celebrating the 'topping out' of their expanded campus, Craig's latest step forward...

NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

Appy Pie Secures Patent for AI Driven App Building

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...

Celina Graves Joins Expanding GoLive Streamers Platform

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

Newsom's Veto Sparks Controversy Over Wildfire Insurance

A Flames of Controversy Light Up California's Insurance Arena Some days, you look at the headlines and just think, "What the heck is going on here?" When Governor Gavin Newsom struck down two critical bills designed to help wildfire survivors, it wasn't just bureaucratic arm-wrestling. It landed like a gut punch to a state already licking its wounds from raging wildfires....

RiskScout Rides High on Funding, Tackles Financial Crime

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

New Leadership at Newmark: Tech Focus Amplified

A Strategic Leap in Tech Leadership Newmark Group, Inc. (NASDAQ: NMRK) has handed the digital reins to Mike Whitaker, bringing him on board as Group Chief Information Officer. If you're in the loop with commercial real estate, this shakeup shouldn't come as a surprise. Newmark's been pretty gung-ho about tightening their tech playbook, and Whitaker's appointment is just...

Colson Group Expands with Algood Acquisition

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

SOA Elects New Leaders for 2026: A Look Ahead

A New Lineup for SOA's Board in 2026 On the financial frontlines, few organizations hold the clout that the Society of Actuaries (SOA) wields. With their latest round of elections completed, they've named five fresh Board members along with both a new President Elect and Vice Chair for the upcoming 2026-2027 term. These folks are gearing up to take the stage right after...